The Centers for Medicare & Medicaid Services Friday finalized policy and technical changes to the Medicare Advantage and prescription drug benefit for contract year 2023. To improve MA plan oversight, the final rule would reinstate plan reporting on medical loss ratio requirements that were relaxed in 2017; require plans to demonstrate a sufficient provider network when applying for a new or expanded contract; strengthen CMS’s ability to evaluate plan performance when reviewing proposals for new or expanded contracts; require plans to provide certain materials to beneficiaries in culturally and linguistically appropriate ways; and strengthen oversight of third-party marketing organizations, among other consumer protection provisions. The rule also codifies provisions intended to improve and better assess quality for special needs plans that serve beneficiaries dually eligible for Medicare and Medicaid. 

Related News Articles

Headline
The AHA July 3 released the Health Care Plan Accountability Update for the second quarter of 2025. The update covers the latest developments in Medicare…
Headline
The Departments of Justice and Health and Human Services today announced the creation of the DOJ-HHS False Claims Act Working Group to combat health care fraud…
Headline
A report released June 17 by NORC at the University of Chicago, commissioned by the Coalition to Strengthen America’s Healthcare, found that patients enrolled…
Headline
The Centers for Medicare and Medicaid Services May 30 released a notice requesting comments on a proposed Medicare Advantage service level data collection…
Headline
The Government Accountability Office May 29 released a report recommending the Centers for Medicare & Medicaid Services target behavioral health services…
Headline
The Centers for Medicare & Medicaid Services May 21 announced it will immediately begin annual audits of all Medicare Advantage plans and work to clear a…